Key result
Aging induces alterations in visceral fat cellularity, metabolic pathways, and a pro-inflammatory secretory phenotype, with candidates like ADIPOQ-ADIPOR1 mediating visceral fat-liver crosstalk.
Why the study?
Visceral fat mass increases with age and relates to age-related diseases, but little is known about age-related molecular and cellular changes in human visceral fat.
Observational (n=355)
Answers are grounded in this paper and cite their sources.
Age-related visceral fat changes may contribute to liver dysfunction; leaves open mechanistic targets for age-related metabolic disease.
Aging causes alterations in body composition. Specifically, visceral fat mass increases with age and is associated with age-related diseases. The pathogenic potential of visceral fat accumulation has been associated with its anatomical location and metabolic activity. Visceral fat may control systemic metabolism by secreting molecules that act in distal tissues, mainly the liver, through the portal vein. Currently, little is known about age-related changes in visceral fat in humans. Aiming to identify molecular and cellular changes occurring with aging in the visceral fat of humans, we analyzed publicly available transcriptomic data of 355 omentum samples from the Genotype-Tissue Expression portal (GTEx) of 20–79-year-old males and females. We identified the functional enrichment of genes associated with aging, inferred age-related changes in visceral fat cellularity by deconvolution analysis, profiled the senescence-associated secretory phenotype of visceral adipose tissue, and predicted the connectivity of the age-induced visceral fat secretome with the liver. We demonstrate that age induces alterations in visceral fat cellularity, synchronous to changes in metabolic pathways and a shift toward a pro-inflammatory secretory phenotype. Furthermore, our approach identified candidates such as ADIPOQ-ADIPOR1/ADIPOR2, FCN2-LPR1, and TF-TFR2 to mediate visceral fat-liver crosstalk in the context of aging. These findings cast light on how alterations in visceral fat with aging contribute to liver dysfunction and age-related disease etiology.
No takes yet. Share an insight, caveat, or question.
Moraes et al. (2023) conducted an observational in Aging (n=355). Aging was evaluated on Age-related changes in visceral fat cellularity, metabolic pathways, and secretory phenotype. Aging induces alterations in visceral fat cellularity, metabolic pathways, and a pro-inflammatory secretory phenotype, with candidates like ADIPOQ-ADIPOR1 mediating visceral fat-liver crosstalk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: